MarginsXMarginsX
Home › Markets › Health Care › OBIO

Orchestra BioMed Holdings Inc. (OBIO)

OBIO trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$7.12
-1.79% on the day
Market cap
$560.4M
Small cap
Revenue · 2025
$33.5M
+1169.2% on 2024
Net income · 2025
-$52.7M
-157.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/0001104659-26-026754-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerOBIO on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryUnited States
IPO year2020
SEC CIK0001814114
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$33.5M
Net income-$52.7M
Operating income-$51.8M
Net margin-157.4%
Operating margin-154.7%
Revenue growth+1169.2%
Cash$34.7M
Total assets$114.9M
P/E (computed)Net income was not positive
P/S (computed)16.7×

Warning signs

Cash runway
5.3 months
$27.8M cash at September 30, 2026
Share count, 1 year
+39.4%
2025-11-06 to 2026-11-09 · +120.2% over 3 years
Going-concern doubt
No
10-Q filed November 10, 2026
Insider net buying, 12 months
$22K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-10
Cash and burn$27.8M cash; operating cash flow -$15.8M a quarter.Report 2026-09-30
Shares outstanding78,704,957 (2026-11-09); 56,464,731 a year earlier; 35,743,972 three years earlier.Cover page 2026-11-09
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-11-06
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Philadelphia, Pennsylvania, United StatesPCAOB Form AP 2026-03-27
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $280K, sold $258K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$91K-$18.8M-$19.5M$27.8MNo debt tags$31.2M10-Q 2026-11-10
Q2 2026
2026-06-30
$88K-$23.8M-$19.3M$20.5MNo debt tags$32.0M10-Q 2026-08-10
Q1 2026
2026-03-31
$110K-$20.7M-$22.2M$28.4M$15.0M$32.7M10-Q 2026-05-12
Q4 2025
2025-12-31
$30.9M$6.2M-$2.3M$34.7M$15.0M$33.5M10-K 2026-03-12
Q3 2025
2025-09-30
$861K-$20.8M-$14.6M$42.0M$15.0M$2.8M10-Q 2026-11-10
Q2 2025
2025-06-30
$836K-$19.4M-$15.5M$18.7M$15.0M$2.9M10-Q 2026-08-10
Q1 2025
2025-03-31
$868K-$18.8M-$16.6M$18.3M$15.0M$2.9M10-Q 2026-05-12
Q4 2024
2024-12-31
$253K-$16.2M-$13.5M$22.3M$15.0M$2.6M10-K 2026-03-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-11-06
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-11-10
Latest current report
FORM 8-K
8-K2026-11-09
Latest proxyDEFA14A2026-06-16

Source: SEC EDGAR submissions feed, 422 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+27.6%
1 month+26.7%
3 months+62.9%
Year to date+74.7%
1 year+73.4%
From 52-week high0.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
TLRYTilray Brands Inc. Common Stock$2.34-3.70%$345.8M
SNDLSNDL Inc. Common Shares$1.34-2.19%$326.0M
ACBAurora Cannabis Inc. Common Shares$4.61-6.68%$303.1M
CRONCronos Group Inc. Common Share$3.27-3.25%$1.2B
USNAUSANA Health Sciences Inc.$13.54+2.27%$250.3M
CGCCanopy Growth Corporation Common Shares$0.5460-2.71%$231.2M
MDWDMediWound Ltd.$13.55+5.04%$195.0M
RLXRLX Technology Inc.$1.53-1.92%$1.9B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier